See leaflet
Temaste®
trifluridine + tipiracil
Indications
- Treatment of patients with metastatic colorectal cancer previously treated or who are not candidates for treatment with fluoropyrimidines, oxaliplatin, irinotecan, anti-VEGF and anti-EGFR agents.
Presentations
- 15 mg/6.14 mg x 20 coated tablets
- 15 mg/6.14 mg x 60 coated tablets
- 20 mg/8.19 mg x 20 coated tablets
- 20 mg/8.19 mg x 60 coated tablets
- 15 mg/6.14 mg x 20 coated tablets
- 15 mg/6.14 mg x 60 coated tablets
- 20 mg/8.19 mg x 20 coated tablets
- 20 mg/8.19 mg x 60 coated tablets